Silk Road Medical (SILK) Reaches New 12-Month Low at $32.50

Silk Road Medical Inc (NASDAQ:SILK) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $32.50 and last traded at $33.43, with a volume of 1290 shares trading hands. The stock had previously closed at $34.16.

In other news, major shareholder X Finance L.P. Wp sold 900,000 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $20.00, for a total value of $18,000,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

COPYRIGHT VIOLATION WARNING: “Silk Road Medical (SILK) Reaches New 12-Month Low at $32.50” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.com-unik.info/2019/04/18/silk-road-medical-silk-reaches-new-12-month-low-at-32-50.html.

About Silk Road Medical (NASDAQ:SILK)

Silk Road Medical, Inc operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices.

Further Reading: Limitations of the P/E Growth ratio

Receive News & Ratings for Silk Road Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silk Road Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit